CD4 and neoplasm: Expanding on this, we conducted proteomic analyses to examine the TME-specific changes induced by LDRT, revealing elevated levels of Granzyme B, MIP1α, and CD137 (4-1BB) within tumor-infiltrating CD4 + T cells, signifying enhanced activation and effector functionality.